Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Outer membrane vesicle vaccines
Francesca Micoli, Calman A. MacLennan
Seminars in Immunology (2020) Vol. 50, pp. 101433-101433
Open Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

The role of vaccines in combatting antimicrobial resistance
Francesca Micoli, Fábio Bagnoli, Rino Rappuoli, et al.
Nature Reviews Microbiology (2021) Vol. 19, Iss. 5, pp. 287-302
Open Access | Times Cited: 358
Bacterial Outer Membrane Vesicles: From Discovery to Applications
Mariana G. Sartorio, Evan J. Pardue, Mario F. Feldman, et al.
Annual Review of Microbiology (2021) Vol. 75, Iss. 1, pp. 609-630
Open Access | Times Cited: 226
Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
Yujing Huang, Xiaohan Guo, Yi Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 147
Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies
Raquel Cid, Jorge Bolı́var
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1072-1072
Open Access | Times Cited: 119
The tremendous biomedical potential of bacterial extracellular vesicles
Junhua Xie, Qiqiong Li, Freddy Haesebrouck, et al.
Trends in biotechnology (2022) Vol. 40, Iss. 10, pp. 1173-1194
Open Access | Times Cited: 114
Extracellular Vesicles from Akkermansia muciniphila Elicit Antitumor Immunity Against Prostate Cancer via Modulation of CD8+ T Cells and Macrophages
Zhong‐Wei Luo, Kun Xia, Yi-Wei Liu, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 2949-2963
Open Access | Times Cited: 107
Antimicrobial Resistance and Recent Alternatives to Antibiotics for the Control of Bacterial Pathogens with an Emphasis on Foodborne Pathogens
Yosra A. Helmy, Khaled Taha-Abdelaziz, Hanan Abd El-Halim Hawwas, et al.
Antibiotics (2023) Vol. 12, Iss. 2, pp. 274-274
Open Access | Times Cited: 102
Extracellular vesicles: Emerging tools as therapeutic agent carriers
Shan Liu, Xue Wu, Sutapa Chandra, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 10, pp. 3822-3842
Open Access | Times Cited: 87
Salmonellosis: An Overview of Epidemiology, Pathogenesis, and Innovative Approaches to Mitigate the Antimicrobial Resistant Infections
Bibek Lamichhane, Asmaa M. M. Mawad, Mohammed A. Saleh, et al.
Antibiotics (2024) Vol. 13, Iss. 1, pp. 76-76
Open Access | Times Cited: 80
Applications of synthetic biology in medical and pharmaceutical fields
Xu Yan, Xu Liu, Cuihuan Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Fusobacterium nucleatum outer membrane vesicles activate autophagy to promote oral cancer metastasis
Gang Chen, Chunna Gao, Shan Jiang, et al.
Journal of Advanced Research (2023) Vol. 56, pp. 167-179
Open Access | Times Cited: 47
Biofunctional lipid nanoparticles for precision treatment and prophylaxis of bacterial infections
Xinran Peng, Jiaoyu Chen, Yingying Gan, et al.
Science Advances (2024) Vol. 10, Iss. 14
Open Access | Times Cited: 24
Advances in Engineered Macrophages: A New Frontier in Cancer Immunotherapy
Shuaixi Yang, Yuhang Wang, Jiachi Jia, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 22
RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2
Rang Feng, Ruo‐Yi Xue, Chang Liu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance
Zhuang Zhu, Fabio Antenucci, Kasper Rømer Villumsen, et al.
mBio (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 68
Pseudomonas aeruginosa: Recent Advances in Vaccine Development
Matthew Killough, Aoife M. Rodgers, Rebecca J. Ingram
Vaccines (2022) Vol. 10, Iss. 7, pp. 1100-1100
Open Access | Times Cited: 52
Towards a Four-Component GMMA-Based Vaccine against Shigella
Francesca Micoli, Usman Nakakana, Francesco Berlanda Scorza
Vaccines (2022) Vol. 10, Iss. 2, pp. 328-328
Open Access | Times Cited: 45
Strengths and weaknesses of pneumococcal conjugate vaccines
Francesca Micoli, Maria Rosaria Romano, Filippo Carboni, et al.
Glycoconjugate Journal (2023) Vol. 40, Iss. 2, pp. 135-148
Open Access | Times Cited: 41
Extracellular vesicles as next generation immunotherapeutics
David W. Greening, Rong Xu, Anukreity Ale, et al.
Seminars in Cancer Biology (2023) Vol. 90, pp. 73-100
Closed Access | Times Cited: 41
Outer membrane vesicles: A bacterial-derived vaccination system
Linda A. Lieberman
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 39
Emerging role of bacterial outer membrane vesicle in gastrointestinal tract
Cheng‐mei Tian, Meifeng Yang, Haoming Xu, et al.
Gut Pathogens (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 36
Bacterial extracellular vesicles: A position paper by the microbial vesicles task force of the Chinese society for extracellular vesicles
Minghui Wen, Jingyu Wang, Zihao Ou, et al.
Deleted Journal (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 27
Bacterial extracellular vesicles and their interplay with the immune system
Étienne Doré, Éric Boilard
Pharmacology & Therapeutics (2023) Vol. 247, pp. 108443-108443
Closed Access | Times Cited: 26
Salmonella Combination Vaccines: Moving Beyond Typhoid
Calman A. MacLennan, Jeffrey D Stanaway, Stephanie Grow, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. Supplement_1, pp. S58-S66
Open Access | Times Cited: 23
Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis
Haoran Wang, Jian-Kang Mu, Yexing Chen, et al.
Advanced Science (2024) Vol. 11, Iss. 17
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top